首页> 外文期刊>British Journal of Dermatology >Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes.
【24h】

Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes.

机译:由于KRT5突变而引起的大疱表皮松解:与突变相关的细胞脆性差异和三甲胺N-氧化物在培养的原代角质形成细胞中的保护作用。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Epidermolysis bullosa simplex (EBS) is a mechanobullous skin fragility disease characterized by cytolysis of basal keratinocytes and intraepidermal blistering often caused by mutations in keratin genes (KRT5 or KRT14). No remedies exist for these disorders presenting a need for development of novel therapies. OBJECTIVES: To identify new genotype-phenotype relationships in vivo and in cultured primary EBS keratinocytes in vitro, and to study the cytoskeletal stabilizing effects of trimethylamine N-oxide (TMAO) in heat-stressed EBS cells. METHODS: Genomic DNA and cDNA samples from three Swedish patients with EBS were analysed for keratin mutations. Primary EBS keratinocyte cultures were established, heat stressed with and without added TMAO, followed by evaluation of cellular fragility. RESULTS: In addition to the previously reported KRT5 mutation (V186L) in one patient, two patients were found to have a novel I183M and recurrent E475G replacements in KRT5. Cultured EBS keratinocytes did not exhibit keratin aggregates or cell loss, except in the patient with the p.I183M mutation who showed 3% aggregates and 2% cell loss. Upon transient heat stress the number of aggregate-containing cells increased to 21%, 27% and 13%, respectively, in the p.I183M, p.E475G and p.V186L mutant cells. Interestingly, pretreatment with TMAO prior to heat stress, dose dependently reduced the number of aggregate-containing cells and cell loss. CONCLUSION: These results revealed a genotype-phenotype correlation in EBS keratinocytes upon heat stress and suggest protein stabilization as a new therapeutic strategy.
机译:背景:大疱性表皮松解症(EBS)是一种机械性球囊性皮肤脆弱性疾病,其特征在于基底角化细胞的细胞溶解和表皮内起泡,通常是由角蛋白基因(KRT5或KRT14)的突变引起的。目前尚无针对这些疾病的药物,因此需要开发新的疗法。目的:鉴定体内和体外培养的原代EBS角质形成细胞的新基因型-表型关系,并研究三甲胺N-氧化物(TMAO)在热应激EBS细胞中的细胞骨架稳定作用。方法:分析了瑞典三名EBS患者的基因组DNA和cDNA样本的角蛋白突变。建立主要的EBS角质形成细胞培养物,在添加和不添加TMAO的情况下进行热应激,然后评估细胞的脆性。结果:除了先前报道的一名患者的KRT5突变(V186L),还有两名患者在KRT5中具有新型I183M和复发性E475G替代。培养的EBS角质形成细胞没有显示出角蛋白聚集或细胞丢失,只有患有p.I183M突变的患者显示出3%聚集和2%细胞丢失。在短暂的热胁迫下,p.I183M,p.E475G和p.V186L突变细胞中含聚集体的细胞数量分别增加到21%,27%和13%。有趣的是,在热应激之前用TMAO预处理可以剂量依赖性地减少含聚集体的细胞数量和细胞损失。结论:这些结果揭示了热应激后EBS角质形成细胞的基因型与表型的相关性,并表明蛋白质稳定是一种新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号